Prices delayed ≤15 min
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provi
Frequently Asked Questions about UNH
What does UnitedHealth Group Incorporated (UNH) do?
UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It has four primary segments: UnitedHealthcare, which provides consumer-oriented health benefit plans; Optum Health, focusing on health services; Optum Insight, offering data analytics; and Optum Rx, which manages pharmacy benefits.
Is UNH stock a good investment in 2026?
Considering the revenue growth of 11.8% and a robust market capitalization of $300.58 billion, UNH shows potential as a solid investment. However, the absence of a P/E ratio complicates valuation comparisons, suggesting investors should carefully assess future earnings and market conditions.
What is UnitedHealth Group Incorporated's market capitalisation and stock price?
As of now, UnitedHealth Group's stock price is $331.83, with a market capitalization of approximately $300.58 billion. This positions the company well within its sector, especially when considering its 52-week high of $606.36 and low of $234.60.
Does UNH pay dividends to shareholders?
UnitedHealth Group does not currently pay dividends to its shareholders. Instead, the company appears to reinvest its earnings into growth initiatives, as indicated by its significant free cash flow of $16.07 billion.
How profitable is UnitedHealth Group Incorporated?
UnitedHealth Group reported a net income of $12.06 billion, translating to a net margin of 2.7%. While ROE data is not available, the company's strong free cash flow suggests healthy profitability and operational efficiency.
What is UNH's P/E ratio and is the stock overvalued?
UnitedHealth Group's P/E ratio is currently not applicable, which may indicate that the company is not generating positive earnings per share at this time. This lack of a P/E ratio makes it challenging to determine if the stock is overvalued compared to its healthcare sector peers.
How much debt does UnitedHealth Group Incorporated have?
Currently, UnitedHealth Group does not disclose its debt-to-equity ratio, indicating that debt levels may not be a significant concern. Additionally, with a current ratio of 0.79 and a robust free cash flow of $16.07 billion, the company's balance sheet appears relatively healthy.
What is UNH's 52-week trading range?
The 52-week trading range for UnitedHealth Group is between $234.60 and $606.36. The current stock price of $331.83 is situated below the 50-day moving average of $335.41 and the 200-day moving average of $352.53.
Is UNH a growth stock or value stock?
UnitedHealth Group is primarily considered a growth stock, evidenced by its revenue growth rate of 11.8%. However, the lack of EPS data makes it difficult to perform a complete PEG ratio analysis, which could provide further insights into its valuation.
What are the main risks of investing in UNH?
Investing in UnitedHealth Group carries risks such as its low beta of 0.43, indicating lower volatility compared to the market, but this may also reflect a lack of aggressive growth. Additionally, challenges related to competition in the healthcare sector and the absence of a dividend may deter some investors.